Table 3. Diagnostic accuracy for recurrence.
|
Low risk group (compared with other groups) |
High risk group (compared with other groups) |
||||||
|---|---|---|---|---|---|---|---|
| RSS | Diagnostic accuracy statistics | Value | Low 95% CI | High 95% CI | Value | Low 95% CI | High 95% CI |
| PORTEC-1 (Creutzberg et al, 2000a) | Sensitivity | 0.132 | 0.074 | 0.216 | 0.451 | 0.357 | 0.545 |
| Specificity | 0.647 | 0.636 | 0.664 | 0.790 | 0.772 | 0.809 | |
| PPV | 0.069 | 0.039 | 0.112 | 0.297 | 0.236 | 0.360 | |
| NPV | 0.791 | 0.777 | 0.811 | 0.880 | 0.859 | 0.900 | |
| ODA | 0.562 |
0.734 |
|||||
| GOG-99 (Keys et al, 2004) | Sensitivity | 0.275 | 0.193 | 0.371 | 0.440 | 0.347 | 0.534 |
| Specificity | 0.448 | 0.432 | 0.467 | 0.803 | 0.785 | 0.822 | |
| PPV | 0.089 | 0.063 | 0.121 | 0.305 | 0.241 | 0.371 | |
| NPV | 0.758 | 0.731 | 0.790 | 0.879 | 0.859 | 0.899 | |
| ODA | 0.420 |
0.743 |
|||||
| SEPAL (Todo et al, 2010) | Sensitivity | 0.187 | 0.118 | 0.278 | 0.264 | 0.187 | 0.350 |
| Specificity | 0.522 | 0.508 | 0.540 | 0.881 | 0.866 | 0.898 | |
| PPV | 0.071 | 0.045 | 0.106 | 0.304 | 0.215 | 0.403 | |
| NPV | 0.765 | 0.745 | 0.791 | 0.859 | 0.844 | 0.875 | |
| ODA | 0.457 |
0.769 |
|||||
| ESMO (Colombo et al, 2013) | Sensitivity | 0.176 | 0.109 | 0.266 | 0.451 | 0.359 | 0.542 |
| Specificity | 0.496 | 0.482 | 0.513 | 0.844 | 0.826 | 0.862 | |
| PPV | 0.064 | 0.040 | 0.097 | 0.363 | 0.289 | 0.437 | |
| NPV | 0.753 | 0.733 | 0.780 | 0.886 | 0.867 | 0.905 | |
| ODA | 0.467 |
0.773 |
|||||
| ESMO modifieda (Bendifallah et al, 2014) | Sensitivity | 0.179 | 0.109 | 0.273 | 0.452 | 0.357 | 0.548 |
| Specificity | 0.508 | 0.494 | 0.527 | 0.837 | 0.818 | 0.856 | |
| PPV | 0.067 | 0.041 | 0.103 | 0.355 | 0.280 | 0.430 | |
| NPV | 0.757 | 0.736 | 0.785 | 0.885 | 0.865 | 0.905 | |
| ODA | 0.453 | 0.776 | |||||
Abbreviations: ESMO=European Society for Medical Oncology; GOG=Gynecologic Oncology Group; NPV=negative predictive values; ODA=overall diagnostic accuracy; PORTEC=Post Operative Radiation Therapy in Endometrial Carcinoma; PPV=positive predictive values; SEPAL=Survival effect of para-aortic lymphadenectomy.
Intermediate-risk ESMO/LVSI+ and high risk groups compared with intermediate risk ESMO/LVSI- and low risk.